µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© >
i@gR
nb0<.ICF%R
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© fbo64$!hZ
1¡¢Co-stimulators (or co-stimulating molecules) 3]xnKb|W
2¡¢NK-kB eQ9{J9)?
3¡¢Immunoglobulin superfamily bis/Nfr]
4¡¢antigen-presenting cell (APC) !i}G>*XH,
5¡¢death domain q2gc.]K\
6¡¢CCR and CXCR >fs-_
>1d
7¡¢Lectin (or mitogen) V!"^6)
8¡¢Clusters of differentiation, CD) G.B^C)guu
9¡¢B7 family /1
n}IRuw
10¡¢Cytotoxic T lymphocyte, CTL) ;M4N=G Wd4
11¡¢IL-15 and IL-15 receptor (IL-15R) Arfq
12¡¢MHC restriction C. 8>
13¡¢Affinity-chromatography ?ADk`ts~,}
14¡¢Cyctosprin A, CsA |a\s}M1
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) l\$_t2U
'*-X3p
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© S$muV9z2=
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 s8eiq`6\H}
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ o~es>;
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ / HaS.
?7a<V+V:
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© A=h`Z^8\B
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ +H="5uO<
ѪҺ²¡Ñ§×¨Òµ£º ]p0m6}B
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿